Zentiva Refreshes Senior Leadership Team
Soňa Porubská Takes Over As Global Head Of Corporate Affairs
Zentiva has made some high-profile changes to its senior leadership team in recent weeks. Former general manager of its Czech Republic and Slovakia business Soňa Porubská is taking on a new role as global head of corporate affairs, succeeded by Boris Sananes.
You may also be interested in...
Zentiva has announced that Steffen Saltofte will become CEO of the privately-owned generics firm, replacing Nick Haggar who has led the company for over four years.
Zentiva gains semi-exclusive commercialization rights to Biocon’s liraglutide drug-device combination in 30 countries, following a string of similar deals for the company since its 2018 acquisition.
Finalists across all 14 categories of the Global Generics & Biosimilars Awards 2021 have been revealed ahead of the awards ceremony on 10 November, following record entries this year.